The Filing Desk

Mirum Pharmaceuticals vs OPKO Health

Mirum Pharmaceuticals MIRM · OPKO Health OPK · Pharmaceuticals

OPKO Health reported revenue of $607 million in fiscal 2025, 1.2 times Mirum Pharmaceuticals' $521 million in fiscal 2025. Mirum Pharmaceuticals' revenue grew 54.7% in its latest year, and OPKO Health's fell 14.9%. Mirum Pharmaceuticals had an operating margin of -4.2%, against -19.4% at OPKO Health. Free cash flow was $55 million at Mirum Pharmaceuticals and −$191 million at OPKO Health.

Side by side

Mirum PharmaceuticalsOPKO Health
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$521M$607M
Revenue growth54.7%−14.9%
Revenue growth a year, last 5 years—−15.8%
Gross margin—33.9%
Operating margin−4.2%−19.4%
Net margin−4.5%−37.2%
Free cash flow$55M−$191M
Free cash flow margin10.5%−31.4%
Return on capital−7.1%−7.0%
Net debt to EBITDA−34.9x—
Dividends and buybacks$0M$47M
Change in diluted share count5.6%8.2%
Last close$93.99$1.68
P/E at the last close——
Insider trades, last 12 monthsbought $9.0 million, sold $42.9 million—
Piotroski F-score5 of 84 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Mirum PharmaceuticalsOPKO Health
Operating margin
Percent of revenue
Mirum PharmaceuticalsOPKO Health
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Mirum PharmaceuticalsOPKO Health

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Mirum Pharmaceuticals and OPKO Health pages.